The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2009, 182, 6639 -6643
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0900638

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morris, G. P.
Right arrow Articles by Allen, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morris, G. P.
Right arrow Articles by Allen, P. M.

Cutting Edge: Highly Alloreactive Dual TCR T Cells Play a Dominant Role in Graft-versus-Host Disease1

Gerald P. Morris and Paul M. Allen2

Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110

Alloreactivity is the response of T cells to MHC molecules not encountered during thymic development. A small population (1–8%) of peripheral T cells in mice and humans express two TCRs due to incomplete allelic exclusion of TCR{alpha}, and we hypothesized they are highly alloreactive. FACS analysis of mouse T cell MLR revealed increased dual TCR T cells among alloreactive cells. Quantitative assessment of the alloreactive repertoire demonstrated a nearly 50% reduction in alloreactive T cell frequency among T cells incapable of expressing a secondary TCR. We directly demonstrated expansion of the alloreactive T cell repertoire at the single cell level by identifying a dual TCR T cell with distinct alloreactivities for each TCR. The importance of dual TCR T cells is clearly demonstrated in a parent-into-F1 model of graft-vs-host disease, where dual TCR T cells comprised up to 60% of peripheral activated T cells, demonstrating a disproportionate contribution to disease.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by National Institutes of Health Grant AI-061173 (to P.M.A.) and the W. M. Keck Foundation Fellowship in Molecular Medicine (to G.P.M.).

2 Address correspondence and reprint requests to Dr. Paul M. Allen, Department of Pathology and Immunology, 660 South Euclid, Box 8118, St. Louis, MO 63110. E-mail address: pallen{at}wustl.edu

3 Abbreviations used in this paper: GVHD, graft-vs-host disease; BMC, bone marrow cell.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
P. Kumar, A. Vahedi-Faridi, W. Saenger, E. Merino, J. A. Lopez de Castro, B. Uchanska-Ziegler, and A. Ziegler
Structural Basis for T Cell Alloreactivity among Three HLA-B14 and HLA-B27 Antigens
J. Biol. Chem., October 23, 2009; 284(43): 29784 - 29797.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.